Broadcom

Form 144 Federal Realty Investment Trust For: 30 September By Investing.com

This article announces the filing of Form 144 for Federal Realty Investment Trust (FRT) for September 30. Form 144 is a notice of the intent to sell restricted securities. The brief announcement provides the company name and filing date, indicating a planned sale of shares by insiders or affiliates.

Broadcom Has More Than One Way to Win. Here’s Where I See the Stock Going

Broadcom (AVGO) recently reported its strongest quarter in company history, with AI semiconductor revenue surging 221% year-over-year, yet its stock remains significantly below its 52-week high. Despite risks like customer concentration and gross margin compression, the company has secured substantial AI revenue commitments for future fiscal years. Analysts project a strong upside, with 24/7 Wall St. setting a $427.46 price target, reflecting a "buy" rating due to its compelling valuation compared to competitors like NVIDIA and AMD.

Form 13D/A Inflection Point Acquisition Corp. V For: 26 September

This article announces the filing of Form 13D/A for Inflection Point Acquisition Corp. V, pertaining to the date of September 26. The content is primarily a placeholder for the SEC filing itself and includes no additional details or analysis regarding the filing. It appears to be an automated notification of the document's availability.

Form 4 Charles Schwab Corp For: 25 September By Investing.com

The article reports on a Form 4 filing for Charles Schwab Corp dated September 25. It is a very brief news item, primarily serving as a placeholder or announcement of the filing rather than providing detailed analysis. The content mainly consists of financial market data and other news headlines from Investing.com.

Tower Semiconductor Ltd Stock (TSEM) Moved Up by 7.64% on Sep 25: What Signal Does It Send?

Tower Semiconductor Ltd (TSEM) saw its stock rise by 7.64% on September 25th, driven by an "Outperform" rating from Mizuho Securities, which highlighted the company's strong position in silicon photonics for next-generation optical connectivity. The company's annual revenue reached $1.57 billion with a net profit of $220.47 million, and analysts project an average price target of $324.06. However, the stock faces risks including elevated valuation multiples, significant insider selling, and sensitivity to AI infrastructure spending cycles.

Form 144 FORTINET INC For: 25 September By Investing.com

This article announces the filing of Form 144 for Fortinet Inc. on September 25. Form 144 is filed with the SEC by an affiliate of a company when they intend to sell restricted or control securities. The article does not provide details about the transaction, focusing only on the notification itself.

Why Caterpillar Stock Is Trading Higher During Friday's Session

Caterpillar Inc. (NYSE: CAT) shares are trading higher on Friday due to increased investor interest in AI infrastructure buildout and a reduced expectation for another Federal Reserve interest-rate hike. The company's Power Generation segment is experiencing rapid growth, driven by demand from data centers and major orders for natural-gas generator sets and turbines. This physical infrastructure cycle is positively impacting Caterpillar's bottom line, with a 17% year-over-year surge in Power & Energy sales in the second quarter.

Morgan Stanley resets AMAT stock price target by $79

Morgan Stanley has revised its price target for Applied Materials (AMAT) down to $563 from $642, despite raising its 2027 revenue and EPS forecasts due to increased NAND demand. The cut reflects a lowered valuation multiple from 26x to 22x, as the firm believes the stock's current price already accounts for much of the positive business outlook. Despite the price target reduction, it still suggests a 33% upside from its current trading price, with AMAT having seen significant year-to-date and year-over-year gains.

AI Demand Outlook Could Be A Key Test For Texas Instruments Stock (TXN)

Market Comparison Analysis of ASML and Qualcomm

This article provides a market comparison analysis between ASML and Qualcomm, highlighting their financial performances, market competition risks, and investment recommendations. ASML, as a sole manufacturer of EUV lithography machines, shows strong profitability and is recommended for long-term investment despite high valuation. Qualcomm, while having higher revenue, faces vulnerability due to client reliance and a significant one-time tax charge, suggesting its appeal lies in its expansion into automotive and IoT markets.

Cisco Systems (NASDAQ:CSCO) In Focus After Record Fiscal Revenue And AI Security Push

Cisco Systems (NASDAQ:CSCO) reported record fiscal year revenue, driven by strong demand for networking and security across enterprise, service provider, and public sectors. The company is heavily focusing on AI infrastructure, security, and Splunk deployments, positioning its products as essential for large model training and high-speed data center connections. Despite the strong performance, market sentiment was mixed after one brokerage trimmed its price estimate due to growth pace concerns.

Form 4 Medpace Holdings Inc For: 26 September By Investing.com

This article from Investing.com announces the filing of Form 4 for Medpace Holdings Inc. on September 26. It includes stock performance data and various financial market indices.

Form 4 Alphabet Inc Class C For: 26 September By Investing.com

This article from Investing.com is a regulatory Form 4 filing for Alphabet Inc Class C (GOOG) dated September 26. It indicates that there are no comments yet on this particular filing. The article provides financial market data and related news but the core content focuses on the Form 4 announcement.

Form 8K SANUWAVE Health For: 25 September By Investing.com

This article reports that SANUWAVE Health (SNWV) filed a Form 8K on September 25, 2026. The stock was up 3.92% at the time of publication. The filing pertains to financial information for the specified date.

H.C. Wainwright raises Surrozen stock price target on Wnt pathway validation

H.C. Wainwright increased its price target for Surrozen Inc. (NASDAQ:SRZN) to $54 from $44, maintaining a Buy rating, after Merck's positive trial results validated the Wnt pathway. This validation is seen as beneficial for Surrozen's SZN-8141, which is slated to enter clinical trials for diabetic macular edema by year-end 2026. Despite a recent surge in stock price, InvestingPro analysis suggests the stock might be overvalued.

Form 8K Clover Health Investments Corp For: 25 September By Investing.com

This article announces that Clover Health Investments Corp. filed a Form 8K on September 25. The brief report from Investing.com includes the stock symbol CLOV, which experienced a slight decrease of 0.44%.

Form 8K MOSAIC CO For: 25 September By Investing.com

This article from Investing.com announces the filing of a Form 8K by MOSAIC CO on September 25, 2026. The brevity of the article suggests it serves as a notification of the filing rather than an in-depth analysis. It also provides a snapshot of various market data including indices, commodities, and bonds, and trending stocks.